Celine Johanna van de Laar
4PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|May 30, 2024
PERFECTRA: a pragmatic, multicentre, real-life study comparing treat-to-target strategies with baricitinib versus TNF inhibitors in patients with active rheumatoid arthritis after failure on csDMARDs.Celine J van de Laar, Martijn A H Oude Voshaar, Peter Ten Klooster
|Jan 28, 2022
Model-based cost-effectiveness analyses comparing combinations of urate lowering therapy and anti-inflammatory treatment in gout patients.Celine Johanna van de Laar, Carly A Janssen, Matthijs Janssen
|Apr 30, 2020
Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis.Celine J Van De Laar, Martijn A H Oude Voshaar, Walid K H Fakhouri
|Jun 07, 2019
Cost-effectiveness of different treat-to-target strategies in rheumatoid arthritis: results from the DREAM registry.Celine J van de Laar, Martijn A H Oude Voshaar, Harald E Vonkeman
Pageof 1
